My Longevity Docs is categorized under Health Services in New York City, NY and active since 2000.
My Longevity Docs was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number by the NAICS.
If you are seeking more information, feel free to contact Patricia Eugene at the company’s single location by writing to 115 East 57th Street Suite 610
Located in the Galleria Building, New York City, New York NY 10001 or by phoning (212) 644-4300. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | My Longevity Docs |
Contact Person: | Patricia Eugene |
Address: | 115 East 57th Street Suite 610 Located in the Galleria Building, New York City, New York 10001 |
Phone Number: | (212) 644-4300 |
Website Address: | mylongevitydocs.com |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2000 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Health Services |
Share This Business: |
My Longevity Docs was started in 2000 to provide professional Health Services under the SIC code and NAICS code . Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Patricia Eugene for inquiries that concern My Longevity Docs by calling the company number (212) 644-4300, as your correspondence is most welcome.
Additionally, the physical location of the single location of My Longevity Docs can be found at the coordinates 40.76126,-73.96994 as well as the street address 115 East 57th Street Suite 610
Located in the Galleria Building in New York City, New York 10001.
For its online presence, you may visit My Longevity Docs’s website at mylongevitydocs.com and engage with its social media outlets through on Twitter and on Facebook.